Evidence map›Paper›PMID 25926555›Full record

ArticleOncotarget2015

Dysfunctional BLK in common variable immunodeficiency perturbs B-cell proliferation and ability to elicit antigen-specific CD4+ T-cell help.

Ewoud B Compeer, Willemijn Janssen, Annet van Royen-Kerkhof, Marielle van Gijn, Joris M van Montfrans, Marianne Boes

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Combined Single Nucleotide Variants ofChildren (Basel, Switzerland) · 2021
    Article
  6. B Cell Disorders in Children: Part II.Current allergy and asthma reports · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ewoud B CompeerDepartment of Pediatric Immunology, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
Willemijn JanssenDepartment of Pediatric Immunology, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
Annet van Royen-KerkhofDepartment of Pediatric Immunology, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
Marielle van GijnDepartment of Medical Genetics, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
Joris M van MontfransDepartment of Pediatric Immunology, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
Marianne BoesDepartment of Pediatric Immunology, Laboratory of Translational Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, The Netherlands.
University Medical Center Utrecht · NLWilhelmina Children's Hospital · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common Variable Immunodeficiency (CVID) is the most prevalent primary antibody deficiency, and characterized by defective generation of high-affinity antibodies. Patients have therefore increased risk to recurrent infections of the respiratory and intestinal tract. Development of high-affinity antigen-specific antibodies involves two key actions of B-cell receptors (BCR): transmembrane signaling through BCR-complexes to induce B-cell differentiation and proliferation, and BCR-mediated antigen internalization for class-II MHC-mediated presentation to acquire antigen-specific CD4(+) T-cell help.We identified a variant (L3P) in the B-lymphoid tyrosine kinase (BLK) gene of 2 related CVID-patients, which was absent in healthy relatives. BLK belongs to the Src-kinases family and involved in BCR-signaling. Here, we sought to clarify BLK function in healthy human B-cells and its association to CVID.BLK expression was comparable in patient and healthy B-cells. Functional analysis of L3P-BLK showed reduced BCR crosslinking-induced Syk phosphorylation and proliferation, in both primary B-cells and B-LCLs. B-cells expressing L3P-BLK showed accelerated destruction of BCR-internalized antigen and reduced ability to elicit CD40L-expression on antigen-specific CD4(+) T-cells.In conclusion, we found a novel BLK gene variant in CVID-patients that causes suppressed B-cell proliferation and reduced ability of B-cells to elicit antigen-specific CD4(+) T-cell responses. Both these mechanisms may contribute to hypogammaglobulinemia in CVID-patients.

Indexed as

Cell ProliferationLymphocyte ActivationAntigen PresentationB-LymphocytesCD40 LigandCell CommunicationCells, CulturedChildCommon Variable ImmunodeficiencyFemaleGenetic Predisposition to DiseaseGenetic VariationHumansIntracellular Signaling Peptides and ProteinsMalePedigreeBLK protein, humanCD40 LigandIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesReceptors, Antigen, B-Cellsrc-Family KinasesSyk KinaseSYK protein, humanantigen presentationBLKB-lymphoid tyrosine kinasecommon variable immunodeficiencypathologyspleen tyrosine kinase

Identifiers

PMID25926555
PMCPMC4484417
OpenAlexW1576553063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.